Institutional investors purchased a net $31.0 million shares of AZN during the quarter ended June 2016 and now own 11.43% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 6.5 Million shares of AstraZeneca
MANAGED ACCOUNT ADVISORS LLC Bought 5.1 Million shares of AstraZeneca
ARROWSTREET CAPITAL LP Bought 4.1 Million shares of AstraZeneca